title: 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.
abstract: OBJECTIVE
  Standard diagnostic methods are limited for detecting distant metastases in patients with prostate cancer in whom the only evidence of disease after radical prostatectomy is a detectable prostate specific antigen (PSA) level. We evaluated the role of immunoscintigraphy with the radiolabeled monoclonal antibody, 111indium ((111)In)-capromab pendetide, to differentiate between local and distant recurrence in this patient population.
  
  
  METHODS
  We enrolled 183 men who had undergone radical prostatectomy in whom PSA later increased. Gamma camera images were acquired twice after infusion of a single dose of (111)In-capromab pendetide.
  
  
  RESULTS
  Immunoscintigraphy revealed disease in 108 of 181 patients (60%) with interpretable scans. The antibody was localized most frequently to the prostatic fossa (34% of the cases), abdominal lymph nodes (23%) and pelvic lymph nodes (22%). Of the 181 men the scan localized the antibody outside the prostatic fossa in 42%. Half of the positive localizations in the fossa were confirmed by biopsy.
  
  
  CONCLUSIONS
  These findings suggest that immunoscintigraphy with (111)In-capromab pendetide can assist in determining the extent of disease in patients who have increasing PSA after prostatectomy.
authors.affiliation: Veterans Affairs Medical Center, Department of Radiology, University of Iowa, Iowa City, USA.
authors.forename: D
authors.initials: D
authors.lastname: Kahn
authors.forename: R D
authors.initials: RD
authors.lastname: Williams
authors.forename: M J
authors.initials: MJ
authors.lastname: Manyak
authors.forename: M K
authors.initials: MK
authors.lastname: Haseman
authors.forename: D W
authors.initials: DW
authors.lastname: Seldin
authors.forename: J A
authors.initials: JA
authors.lastname: Libertino
authors.forename: R T
authors.initials: RT
authors.lastname: Maguire
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D018450:Disease Progression; D006801:Humans; D007205:Indium Radioisotopes; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D018365:Neoplasm, Residual / Q000000981:diagnostic imaging*; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000601:surgery; D016719:Radioimmunodetection
chemical_list: D000911:Antibodies, Monoclonal; D007205:Indium Radioisotopes; C101315:Capromab Pendetide; D017430:Prostate-Specific Antigen